Pre-IPO Sector – News Update – Week of 1/7/2019:

Last week, Adaptive Biotechnologies signed a $300 million deal with Genentech to develop personalized cancer treatments. Adaptive Biotechnologies may receive more than $2 billion from Genentech if certain milestones are met.

Didi Chuxing is introducing protection insurance and credit services within its app for both its passengers and drivers.

Livongo appointed Lee Shapiro as its CFO. Shapiro was on the Board of Livongo since its inception and previously served as Chair of its Audit Committee.

The news articles and links presented below are available for your reference.



“Adaptive Biotechnologies Signs Blockbuster Deal With Genentech For Personalized Cancer Treatments Worth Up To $2 Billion"


"Didi Launches Lending And Insurance As New Regulation Threatens To Lower Driver Numbers"


"Livongo Names Lee Shapiro Chief Financial Officer"